acclivitytechnologies.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# Robots file User-agent: * Allow: / Disallow: /-_-/api/ Sitemap:
Meta Tags
Title ATI
Description Acclivity Technologies Inc. About us News Contact us News Contact us Acclivity Technologies, Inc. (ATI) is a discovery to preclinical health technologies company located in North Car
Keywords N/A
Server Information
WebSite acclivitytechnologies faviconacclivitytechnologies.com
Host IP 217.160.0.96
Location Germany
Related Websites
Site Rank
More to Explore
acclivitytechnologies.com Valuation
US$764
Last updated: 2023-05-20 07:21:11

acclivitytechnologies.com has Semrush global rank of 0. acclivitytechnologies.com has an estimated worth of US$ 764, based on its estimated Ads revenue. acclivitytechnologies.com receives approximately 88 unique visitors each day. Its web server is located in Germany, with IP address 217.160.0.96. According to SiteAdvisor, acclivitytechnologies.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$764
Daily Ads Revenue US$0
Monthly Ads Revenue US$21
Yearly Ads Revenue US$254
Daily Unique Visitors 5
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
acclivitytechnologies.com. 3599 A acclivitytechnologies.com. 3599 IP: 217.160.0.96
acclivitytechnologies.com. 3599 AAAA acclivitytechnologies.com. 3599 IPV6: 2001:8d8:100f:f000::200
acclivitytechnologies.com. 86400 IN NS NS Record: ns1028.ui-dns.biz.
acclivitytechnologies.com. 86400 IN NS NS Record: ns1019.ui-dns.com.
acclivitytechnologies.com. 86400 IN NS NS Record: ns1038.ui-dns.de.
acclivitytechnologies.com. 86400 IN NS NS Record: ns1020.ui-dns.org.
acclivitytechnologies.com. 3600 MX acclivitytechnologies.com. 3600 MX Record: 10 mx00.ionos.com.
acclivitytechnologies.com. 3600 MX acclivitytechnologies.com. 3600 MX Record: 10 mx01.ionos.com.
HtmlToTextCheckTime:2023-05-20 07:21:11
About us News Contact us News Contact us Acclivity Technologies, Inc. (ATI) is a discovery to preclinical health technologies company located in North Carolina. ATI’s lead drug candidate, ATI-0019, is a novel small molecule for a known atherosclerotic and ischemic disease target not previously known to be druggable by small molecules. Activation of this target reverses cardiovascular disease driver processes, including endothelial dysfunction, endothelial damage and loss of vasculature, inflammatory cell response, smooth muscle cell proliferation and migration, and platelet activation. We are testing and improving the pharmacological properties of ATI-0019, building a library of related compounds, and conducting in vitro and in vivo studies to establish the utility of ATI-0019 to treat our lead disease indication, peripheral artery disease, and its manifestations including intermittent claudication, critical limb ischemia, non-healing wounds, and diabetic foot. ATI-0019 and its
HTTP Headers
HTTP/1.1 301 Moved Permanently
Content-Type: text/html
Connection: keep-alive
Keep-Alive: timeout=15
Date: Sun, 22 Jan 2023 08:40:05 GMT
Server: Apache
Cache-Control: max-age=3600
Location: https://www.acclivitytechnologies.com

HTTP/2 200 
content-type: text/html
content-length: 91523
server: nginx
date: Sun, 22 Jan 2023 08:40:05 GMT
vary: Accept-Encoding
etag: "f5c00e8ec68e04525d833386e024462a"
x-amz-version-id: null
cache-control: no-cache
last-modified: Sat, 21 Jan 2023 16:24:23 GMT
x-cache: MISS from itproxy.1and1.org
x-cache-lookup: MISS from itproxy.1and1.org:3128
via: 1.1 itproxy.1and1.org (squid/4.15)
x-server: itproxy-live-de-kae-bs01
accept-ranges: bytes
strict-transport-security: max-age=15768000